BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 32147862)

  • 1. Counterpoint to Jin et al, On weighted composite scores for early Alzheimer's trials. Pharm Stat. 18 (2):239-47, 2019, DOI: 10.1002/pst.1920.
    Edland SD; Raghavan N; Ard MC
    Pharm Stat; 2020 Jul; 19(4):492-493. PubMed ID: 32147862
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to: Counterpoint to Jin et al, On weighted composite scores for early Alzheimer's trials. Pharm Stat. 18(2):239-47, 2019, DOI: 10.1002/pst.1920.
    Jin K; Dunn B
    Pharm Stat; 2020 Jul; 19(4):494. PubMed ID: 32147934
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to comments on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharm Stat 17(5):593-606, Sep/Oct 2018., DOI: https://doi.org/10.1002/pst.1873.
    Jaki T; Gordon A; Forster P; Bijnens L; Bornkamp B; Brannath W; Fontana R; Gasparini M; Hampson LV; Jacobs T; Jones B; Paoletti X; Posch M; Titman A; Vonk R; Koenig F
    Pharm Stat; 2019 May; 18(3):284-286. PubMed ID: 30868716
    [No Abstract]   [Full Text] [Related]  

  • 4. On weighted composite scores for early Alzheimer's trials.
    Jin K; Cameron B; Dunn B
    Pharm Stat; 2019 Mar; 18(2):239-247. PubMed ID: 30565432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comments on "Properties of the weighted log-rank test in the design of confirmatory studies with delayed effects" by Jose Jimenez, Viktoriya Stalbovskaya, and Byron Jones. Pharm Stat. 18:287-303, 2019, DOI: 10.1002/pst.1923.
    Kundu MG
    Pharm Stat; 2020 Sep; 19(5):733-735. PubMed ID: 32185868
    [No Abstract]   [Full Text] [Related]  

  • 6. Comment on: Ripamonti E, Lloyd CJ. Tests for noninferiority trials with binomial endpoints: A guide to modern and quasi-exact methods for biomedical researchers. Pharm Stat 2019;18:377-387. https://onlinelibrary.wiley.com/doi/10.1002/pst.1929.
    Almendra-Arao F; Sotres-Ramos D
    Pharm Stat; 2020 May; 19(3):350-352. PubMed ID: 31930628
    [No Abstract]   [Full Text] [Related]  

  • 7. Sensitivity of a Preclinical Alzheimer's Cognitive Composite (PACC) to amyloid β load in preclinical Alzheimer's disease.
    Bransby L; Lim YY; Ames D; Fowler C; Roberston J; Harrington K; Snyder PJ; Villemagne VL; Salvado O; Masters CL; Maruff P
    J Clin Exp Neuropsychol; 2019 Aug; 41(6):591-600. PubMed ID: 30924399
    [No Abstract]   [Full Text] [Related]  

  • 8. Pancreastatin-like immunoreactivity in globular dystrophic neurites of senile plaques in brains of patients with Alzheimer's disease.
    Yasuhara O; Akiguchi I; Nakamura S; Kinoshita A; Ikemoto A; Kawamoto Y; Kimura J; Funakoshi A; Tateishi K; McGeer PL
    Neurosci Lett; 1996 Apr; 208(3):167-70. PubMed ID: 8733296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
    Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
    J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic changes in Alzheimer's disease: A leading role behind the courtain? Commentary on "CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease" by Lista et al.
    Diomedi M; Stefani A
    Alzheimers Dement; 2015 Sep; 11(9):1123-4. PubMed ID: 25487913
    [No Abstract]   [Full Text] [Related]  

  • 11. Galantamine for Alzheimer's disease.
    Olin J; Schneider L
    Cochrane Database Syst Rev; 2001; (1):CD001747. PubMed ID: 11279727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Older patients are still under-represented in clinical trials of Alzheimer's disease.
    Banzi R; Camaioni P; Tettamanti M; Bertele' V; Lucca U
    Alzheimers Res Ther; 2016 Aug; 8():32. PubMed ID: 27520290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrillar beta-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer's disease.
    Matsuoka Y; Picciano M; La Francois J; Duff K
    Neuroscience; 2001; 104(3):609-13. PubMed ID: 11440793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Letter on the editorial by Gilles Chopart et al. "early diagnosis of Alzheimer's disease: are we too close to the tree to see the forest?"].
    Dubois B
    Presse Med; 2014 Sep; 43(9):1026. PubMed ID: 25154695
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
    Vos SJ; Verhey F; Frölich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Nobili F; Morbelli S; Frisoni GB; Drzezga A; Didic M; van Berckel BN; Simmons A; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Muscio C; Herukka SK; Salmon E; Bastin C; Wallin A; Nordlund A; de Mendonça A; Silva D; Santana I; Lemos R; Engelborghs S; Van der Mussele S; ; Freund-Levi Y; Wallin ÅK; Hampel H; van der Flier W; Scheltens P; Visser PJ
    Brain; 2015 May; 138(Pt 5):1327-38. PubMed ID: 25693589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ratio of mesial to neocortical temporal lobe blood flow as a predictor of dementia.
    Cohen RM; Andreason PJ; Sunderland T
    J Am Geriatr Soc; 1997 Mar; 45(3):329-33. PubMed ID: 9063279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the clinical relevance of a cognitive composite outcome measure: An analysis of 1414 participants from the 5-year GuidAge Alzheimer's prevention trial.
    Coley N; Gallini A; Ousset PJ; Vellas B; Andrieu S;
    Alzheimers Dement; 2016 Dec; 12(12):1216-1225. PubMed ID: 27423962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive composite score association with Alzheimer's disease plaque and tangle pathology.
    Malek-Ahmadi M; Chen K; Perez SE; He A; Mufson EJ
    Alzheimers Res Ther; 2018 Sep; 10(1):90. PubMed ID: 30205840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Pocket Smell Test: successfully discriminating probable Alzheimer's dementia from vascular dementia and major depression.
    Duff K; McCaffrey RJ; Solomon GS
    J Neuropsychiatry Clin Neurosci; 2002; 14(2):197-201. PubMed ID: 11983795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health utilities in Alzheimer's disease: a cross-sectional study of patients and caregivers.
    Neumann PJ; Kuntz KM; Leon J; Araki SS; Hermann RC; Hsu MA; Weinstein MC
    Med Care; 1999 Jan; 37(1):27-32. PubMed ID: 10413389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.